233 related articles for article (PubMed ID: 30659538)
1. Role of 2-Dimensional Autocorrelation Descriptors in Predicting Antimalarial Activity of Artemisinin and its Aanalogues: A QSAR Study.
Kalra S; Joshi G; Kumar R; Munshi A
Curr Top Med Chem; 2018; 18(31):2720-2730. PubMed ID: 30659538
[TBL] [Abstract][Full Text] [Related]
2. Quantitative structure-activity relationships of the antimalarial agent artemisinin and some of its derivatives - a DFT approach.
Rajkhowa S; Hussain I; Hazarika KK; Sarmah P; Deka RC
Comb Chem High Throughput Screen; 2013 Sep; 16(8):590-602. PubMed ID: 23597248
[TBL] [Abstract][Full Text] [Related]
3. [Progress in studies on the artemisinin (qinghaosu)-type antimalarials].
Chen Y; Zhu SM; Chen HY
Yao Xue Xue Bao; 1998; 33(3):234-9. PubMed ID: 11938970
[No Abstract] [Full Text] [Related]
4. Is artemisinin the only antiplasmodial compound in the Artemisia annua tea infusion? An in vitro study.
Mouton J; Jansen O; Frédérich M; van der Kooy F
Planta Med; 2013 Apr; 79(6):468-70. PubMed ID: 23512495
[TBL] [Abstract][Full Text] [Related]
5. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
6. Rational Design of Antimalarial Drugs Using Molecular Modeling and Statistical Analysis.
Santos CB; Lobato CC; Braga FS; Costa Jda S; Favacho HA; Carvalho JC; Macedo WJ; Brasil Ddo S; Silva CH; Silva Hage-Melim LI
Curr Pharm Des; 2015; 21(28):4112-27. PubMed ID: 26017698
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of Plasmodium falciparum Welch field isolates to infusions prepared from Artemisia annua L. cultivated in the Brazilian Amazon.
Silva LF; Magalhães PM; Costa MR; Alecrim Md; Chaves FC; Hidalgo Ade F; Pohlit AM; Vieira PP
Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):859-66. PubMed ID: 23147140
[TBL] [Abstract][Full Text] [Related]
8. Progress in the research of artemisinin and its analogues as antimalarials: an update.
Sriram D; Rao VS; Chandrasekhara KV; Yogeeswari P
Nat Prod Res; 2004 Dec; 18(6):503-27. PubMed ID: 15595609
[TBL] [Abstract][Full Text] [Related]
9. Artemisone--a highly active antimalarial drug of the artemisinin class.
Haynes RK; Fugmann B; Stetter J; Rieckmann K; Heilmann HD; Chan HW; Cheung MK; Lam WL; Wong HN; Croft SL; Vivas L; Rattray L; Stewart L; Peters W; Robinson BL; Edstein MD; Kotecka B; Kyle DE; Beckermann B; Gerisch M; Radtke M; Schmuck G; Steinke W; Wollborn U; Schmeer K; Römer A
Angew Chem Int Ed Engl; 2006 Mar; 45(13):2082-8. PubMed ID: 16444785
[No Abstract] [Full Text] [Related]
10. Development predictive QSAR models for artemisinin analogues by various feature selection methods: a comparative study.
Abbasitabar F; Zare-Shahabadi V
SAR QSAR Environ Res; 2012 Jan; 23(1-2):1-15. PubMed ID: 22040327
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria.
Avery MA; Muraleedharan KM; Desai PV; Bandyopadhyaya AK; Furtado MM; Tekwani BL
J Med Chem; 2003 Sep; 46(20):4244-58. PubMed ID: 13678403
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking and 3-D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues.
Cheng F; Shen J; Luo X; Zhu W; Gu J; Ji R; Jiang H; Chen K
Bioorg Med Chem; 2002 Sep; 10(9):2883-91. PubMed ID: 12110308
[TBL] [Abstract][Full Text] [Related]
13. A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR.
Cardoso FJ; de Figueiredo AF; da Silva Lobato M; de Miranda RM; de Almeida RC; Pinheiro JC
J Mol Model; 2008 Jan; 14(1):39-48. PubMed ID: 17968600
[TBL] [Abstract][Full Text] [Related]
14. Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
Aratikatla EK; Kalamuddin M; Rana KC; Datta G; Asad M; Sundararaman S; Malhotra P; Mohmmed A; Bhattacharya AK
Eur J Med Chem; 2021 Aug; 220():113454. PubMed ID: 33901900
[TBL] [Abstract][Full Text] [Related]
15. A SAR and QSAR study of new artemisinin compounds with antimalarial activity.
Santos CB; Vieira JB; Lobato CC; Hage-Melim LI; Souto RN; Lima CS; Costa EV; Brasil DS; Macêdo WJ; Carvalho JC
Molecules; 2013 Dec; 19(1):367-99. PubMed ID: 24381053
[TBL] [Abstract][Full Text] [Related]
16. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of benzylamino and alkylamino ether analogues of artemisinin.
O'Neill PM; Bishop LP; Storr RC; Hawley SR; Maggs JL; Ward SA; Park BK
J Med Chem; 1996 Oct; 39(22):4511-4. PubMed ID: 8893847
[TBL] [Abstract][Full Text] [Related]
18. QSAR Study of Artemisinin Analogues as Antimalarial Drugs by Neural Network and Replacement Method.
Abbasitabar F; Zare-Shahabadi V
Drug Res (Stuttg); 2017 Aug; 67(8):476-484. PubMed ID: 28561237
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antimalarial activity and cytotoxicity of 10-aminoethylether derivatives of artemisinin.
Cloete TT; Wilma Breytenbach J; Kock Cd; Smith PJ; Breytenbach JC; N'da DD
Bioorg Med Chem; 2012 Aug; 20(15):4701-9. PubMed ID: 22750008
[TBL] [Abstract][Full Text] [Related]
20. Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites.
Ouji M; Nguyen M; Mustière R; Jimenez T; Augereau JM; Benoit-Vical F; Deraeve C
Bioorg Med Chem Lett; 2021 May; 39():127884. PubMed ID: 33636304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
